Advance Search
HUANG Haifen, CHEN Qingyong, HE Fang, LI Ren. Therapeutic effect and mechanism of individualized treatment for hypertension patients with coronary heart disease under non-invasive cardiac output measurement[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 70-75, 81. DOI: 10.7619/jcmp.20243797
Citation: HUANG Haifen, CHEN Qingyong, HE Fang, LI Ren. Therapeutic effect and mechanism of individualized treatment for hypertension patients with coronary heart disease under non-invasive cardiac output measurement[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 70-75, 81. DOI: 10.7619/jcmp.20243797
shu

Therapeutic effect and mechanism of individualized treatment for hypertension patients with coronary heart disease under non-invasive cardiac output measurement

  • the First People's Hospital of Chenzhou City in Hunan Province, Chenzhou, Hunan, 423000

More Information
  • Received Date: August 26, 2024
  • Revised Date: November 21, 2024
    Graphical Abstract
    • Abstract
  • Objective 

    To investigate the efficacy and mechanism of individualized treatment for hypertension patients with coronary heart disease under non-invasive cardiac output measurement.

    Methods 

    A total of 94 hypertension patients with coronary heart disease in the hospital from January 2020 to August 2022 were selected and randomly divided into two groups, with 47 cases in each group. Control group was treated with conventional treatment, while observation group was treated with individualized treatment under non-invasive cardiac output measurement, and both group were continuously treated for 3 months. Clinical efficacy, the blood pressure control[diastolic blood pressure (DBP), systolic blood pressure (SBP)], cardiac ultrasound parameters[left ventricular end-systolic diameter (LVESD), left ventricular mass index (LVMI), interventricular septal thickness (IVS), left ventricular end-diastolic diameter (LVEDD)], heart rate variability[the standard deviation of the average RR interval (SDANN), the standard deviation of the RR interval of all sinus beats (SDNN), and the proportion of adjacent NN>50 ms in the number of sinus beats (PNN50)], indicators of myocardial injury[α-hydroxybutyrate dehydrogenase (α-HBDH), lactate dehydrogenase (LDH), creatine kinase (CK)], transforming growth factor-β1 (TGF-β1)/pancreatic cancer-deficiency factor (Smads) signaling pathway, and incidence of major adverse cardiovascular events (MACE) were compared between the two groups.

    Results 

    The total effective rate of the observation group was 95.74%, which showed no significant difference compared with 85.11% of the control group (P>0.05). After 1 and 3 months of treatment, the levels of DBP and SBP in both groups were decreased significantly compared with those before treatment (P < 0.05), and the LVMI, IVS, LVEDD and LVESD in the observation group were significantly lower than those in the control group (P < 0.05). After 3 months of treatment, the SDANN, PNN50 and SDNN in observation group were significantly higher than those in control group (P < 0.05), while CK, α-HBDH and LDH as well as the expression levels of TGF-β1RⅠ, TGF-β1RⅡ, Smad1 and Smad2 were significantly lower than those in the control group (P < 0.05). After 3 months of follow-up, the incidence rate of MACE in observation group was 6.38%, which showed no significant difference compared with 14.89% in control group (P>0.05).

    Conclusion 

    Compared with conventional treatment regimen, individualized treatment regimen with non-invasive cardiac output measurement can significantly alleviate myocardial injury, reverse ventricular hypertrophy and improve heart rate variability, and its mechanism may be related to the inhibition of the TGF-β1/Smads signaling pathway.

    • FullText(HTML)
    • References (24)
  • [1]
    中国医疗保健国际交流促进会心血管病学分会. 高血压合并冠心病患者血压管理中国专家共识[J]. 中华医学杂志, 2022, 102(10): 717-728.
    [2]
    FUCHS F D, WHELTON P K. High blood pressure and cardiovascular disease[J]. Hypertension, 2020, 75(2): 285-292.
    [3]
    STEWART R A H, HELD C, KRUG-GOURLEY S, et al. Cardiovascular and lifestyle risk factors and cognitive function in patients with stable coronary heart disease[J]. J Am Heart Assoc, 2019, 8(7): e010641. doi: 10.1161/JAHA.118.010641
    [4]
    LEE J M, LEE S K, RHIM C C, et al. Comparison of volume-controlled, pressure-controlled, and pressure-controlled volume-guaranteed ventilation during robot-assisted laparoscopic gynecologic surgery in the Trendelenburg position[J]. Int J Med Sci, 2020, 17(17): 2728-2734.
    [5]
    国家心血管病中心国家基本公共卫生服务项目基层高血压管理办公室, 国家基层高血压管理专家委员会. 国家基层高血压防治管理指南2020版[J]. 中国循环杂志, 2021, 36(3): 209-220.
    [6]
    中国老年医学学会高血压分会, 国家老年疾病临床医学研究中心中国老年心血管病防治联盟. 中国老年高血压管理指南2019[J]. 中华高血压杂志, 2019, 27(2): 111-135.
    [7]
    曹琴琴, 蒋蔚, 华烨, 等. 卒中发病前高血压控制情况与缺血性脑卒中分型的相关性分析[J]. 实用临床医药杂志, 2021, 25(11): 39-42. doi: 10.7619/jcmp.20211193
    [8]
    于丽丽, 廉炜, 余晓英, 等. 氨氯地平联合阿托伐他汀钙治疗高血压合并冠心病患者的临床研究[J]. 中国临床药理学杂志, 2021, 37(20): 2734-2737.
    [9]
    CHEN Y D, YANG X C, PHAM V N, et al. Resting heart rate control and prognosis in coronary artery disease patients with hypertension previously treated with bisoprolol: a sub-group analysis of the BISO-CAD study[J]. Chin Med J (Engl), 2020, 133(10): 1155-1165.
    [10]
    NUOTIO J, SUVILA K, CHENG S S, et al. Longitudinal blood pressure patterns and cardiovascular disease risk[J]. Ann Med, 2020, 52(3/4): 43-54.
    [11]
    SONG J J, MA Z, WANG J, et al. Gender differences in hypertension[J]. J Cardiovasc Transl Res, 2020, 13(1): 47-54. doi: 10.1007/s12265-019-09888-z
    [12]
    SIMONNEAU G, MONTANI D, CELERMAJER D S, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension[J]. Eur Respir J, 2019, 53(1): 1801913. doi: 10.1183/13993003.01913-2018
    [13]
    SYDYKOV A, MAMAZHAKYPOV A, MARIPOV A, et al. Pulmonary hypertension in acute and chronic high altitude maladaptation disorders[J]. Int J Environ Res Public Health, 2021, 18(4): 1692. doi: 10.3390/ijerph18041692
    [14]
    YILDIZ M, OKTAY A A, STEWART M H, et al. Left ventricular hypertrophy and hypertension[J]. Prog Cardiovasc Dis, 2020, 63(1): 10-21. doi: 10.1016/j.pcad.2019.11.009
    [15]
    谢春林, 张松文. 基于无创心排血量行个体化治疗原发性高血压的临床疗效观察[J]. 中西医结合心脑血管病杂志, 2020, 18(8): 1280-1283.
    [16]
    武玉琳, 齐新, 魏丽萍, 等. 老年高血压患者的无创血流动力学参数与心脏结构变化的关系[J]. 中华老年心脑血管病杂志, 2020, 22(1): 10-14.
    [17]
    SAUGEL B, VINCENT J L. Cardiac output monitoring: how to choose the optimal method for the individual patient[J]. Curr Opin Crit Care, 2018, 24(3): 165-172. doi: 10.1097/MCC.0000000000000492
    [18]
    王小艳, 许健, 钱进, 等. 超高龄持续性心房颤动患者心率变异性与基础临床特征的关系分析[J]. 实用临床医药杂志, 2024, 28(9): 67-72. doi: 10.7619/jcmp.20234217
    [19]
    包一星, 陆叶. 合并室性心律失常的心力衰竭患者心率变异性和心功能变化及其关系[J]. 岭南心血管病杂志, 2021, 27(5): 542-546.
    [20]
    王红平, 傅立军, 顾北音, 等. 原发性高血压患者心率变异性及血压变异性与血管损害的相关性研究[J]. 现代生物医学进展, 2019, 19(10): 1875-1878.
    [21]
    HUANG L, PANG L P, GU Q, et al. Prevalence, risk factors, and survival associated with pulmonary hypertension and heart failure among patients with underlying coronary artery disease: a national prospective, multicenter registry study in China[J]. Chin Med J (Engl), 2022, 135(15): 1837-1845.
    [22]
    PODZOLKOV V I, NEBIERIDZE N N, SAFRONOVA T A. Transforming growth factor-β1, arterial stiffness and vascular age in patients with uncontrolled arterial hypertension[J]. Heart Lung Circ, 2021, 30(11): 1769-1777.
    [23]
    SUN Y, REN J, WU W Z. Effect of miR-34a on hypertension-induced hypertrophic cardiomyopathy in rats via the TGF-β1/Smads signaling pathway[J]. Minerva Med, 2021, 112(3): 405-406.
    [24]
    HUNTER K, LARSEN J A, LOVE H D, et al. Inhibition of transforming growth factor-β improves primary renal tubule cell differentiation in long-term culture[J]. Tissue Eng Part A, 2023, 29(3/4): 102-111.
    • Related Articles

  • Related Articles

    [1]MU Jingli, XU Qingyun, WANG Ruili, YANG Pinni, CHENG Ming, WANG Dan, ZHANG Jin, WANG Yinnan, ZHAO Xingquan, CHANG Liguo, WANG Aili. Effect of overweight on the prognosis of patients with acute mild ischemic stroke or moderate-high risk transient ischemic attack[J]. Journal of Clinical Medicine in Practice, 2024, 28(2): 1-7, 12. DOI: 10.7619/jcmp.20232721
    [2]YIN Yidan, YANG Jianping, SUN Ning, MA Baoying, LIU Xiaoling. Application analysis of intelligent speech follow-up system in secondary prevention of ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2023, 27(22): 1-5. DOI: 10.7619/jcmp.20231413
    [3]WANG Ning, SUN Jun, LIU Yi, FENG Gaojun, LIU Yuanfang, PEI Shuang, YANG Yinxue, ZHANG Zaixing, ZHANG Donghuan, WEN Changming. Changes of thrombomodulin and nitric oxide synthase in patients with acute ischemic stroke and their significance[J]. Journal of Clinical Medicine in Practice, 2023, 27(17): 122-126. DOI: 10.7619/jcmp.20230501
    [4]YOU Jing, HE Miao, ZHOU Feng, LI Weirong. Research progress on roles of blood biomarkers in etiological classification of ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2022, 26(6): 118-122. DOI: 10.7619/jcmp.20214524
    [5]BAO Yingshi, LIU Jianhong, DU Huaping, JIA Xianjun. Value of C-reactive protein combined with neutrophil to lymphocyte ratio in predicting post-stroke depression of patients with ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2021, 25(22): 59-62. DOI: 10.7619/jcmp.20213865
    [6]CAO Qinqin, JIANG Wei, HUA Ye, JIANG Siming, MA Tao. Correlation between premorbid hypertension control and the classification of ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 39-42. DOI: 10.7619/jcmp.20211193
    [7]GUO Siping, YANG Lihui, DONG Wanli. Analysis of prognosis-related risk factors in patients with acute ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 39-41, 46. DOI: 10.7619/jcmp.20201527
    [8]MENG Hao, YANG Linjun, PU Yan. Effect of positive reduction of blood pressure in acute period on reperfusion of patients with acute ischemic stroke by intravenous thrombolysis[J]. Journal of Clinical Medicine in Practice, 2017, (17): 31-34. DOI: 10.7619/jcmp.201717009
    [9]ZHANG Zuonian, WANG Zhiye, NI Mengyuan, XU Jun. Correlation between the levels of serum proinflammatory cytokines and stability of carotid atherosclerotic plaque in patients with acute ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2016, (9): 6-9. DOI: 10.7619/jcmp.201609002
    [10]DENG Yanmei. Analysis of the relevant factors between hyperhomocysteinemia and ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2013, (14): 79-80,83. DOI: 10.7619/jcmp.201314027

  • Cited by

    Periodical cited type(11)

    1. 何丽. 全方位保温措施在剖宫产手术室护理工作中的应用效果分析. 基层医学论坛. 2025(07): 149-152 .
    2. 程龙，秦远征. 全方位保温措施在剖宫产手术室护理工作中的应用效果. 妇儿健康导刊. 2023(01): 162-164 .
    3. 许卉，李海宁，李海红，高冬梅. 责任护理模式下的综合保温措施对腹腔镜子宫切除术患者围术期体温及凝血功能的影响. 国际护理学杂志. 2022(02): 350-353 .
    4. 梁惠甜，唐方元. 全方位保温措施在剖宫产手术室护理工作中的应用. 黑龙江医药. 2022(05): 1227-1229 .
    5. 查玲玲，张海燕，陈婷，符霞，汤立飞. 术中积极保温护理干预对前置胎盘剖宫产产妇术后手术源性低体温的影响. 中国当代医药. 2021(11): 204-206 .
    6. 张驰英，方继红，范家莉，姚小燕，夏寅，葛青，王华梅. 先天性髋关节脱位患儿术中体温精细化护理效果观察. 安徽医学. 2021(09): 1059-1063 .
    7. 欧阳颖. 手术室保温干预对剖宫产产妇低体温发生及新生儿评分的影响. 基层医学论坛. 2021(27): 3957-3958 .
    8. 王小梅. 术中积极保温对剖宫产术后康复的影响分析. 人人健康. 2020(11): 234+233 .
    9. 赵梦茜. 瘢痕子宫合并前置胎盘产妇剖宫产术中低体温的影响因素分析. 中国妇幼保健. 2020(22): 4221-4223 .
    10. 谭彩霞，覃晓琳，韦敏奎. 术中综合保温措施在妇科腹腔镜手术患者中的应用效果. 微创医学. 2020(05): 696-698 .
    11. 王晓燕. 剖宫产手术过程低体温的影响因素分析及预防措施探. 现代医学与健康研究电子杂志. 2019(14): 99-100 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (27) PDF downloads (5) Cited by(12)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return